Clinical Trials Directory

Trials / Unknown

UnknownNCT00397397

Comparative Treatment Study in Patients With Lower Ureteral Stones

Comparative Study in Patients With Lower Ureteral Stones Treated With 10 MG Alfuzosin,10 MG Alfuzosin With Rowatinex, and Rowatinex Alone

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (planned)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

We wish to determine the best treatment for expulsion of lower ureteral stones. Which of the three major treatment protocols is the best treatment of conservative management of ureteral stones?

Detailed description

The study will include 60 patients with lower ureteral stones. The patients will be divided into three groups. The first group will be administered Alfuzosin (10 mg). The second group will be administered a combination of Alfuzosin (10 mg)and Rowatinex (Pinene 31%, Camphene 15%, Anetol 4%, Borneol 10%, Cineol 3%, Fenchenol 4%, Olive Oil 33%). The third group will be administered Rowatinex.

Conditions

Timeline

Start date
2007-01-01
Completion
2007-03-01
First posted
2006-11-09
Last updated
2006-11-09

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00397397. Inclusion in this directory is not an endorsement.